|
|
 |
|
|
|
|
|
|
Print Page | Email Page
|
Gagandeep Singh, Medical Director of the Hepatobiliary and Pancreatic Surgery Program at Saint John’s Health Center
Dr. Gagandeep Singh is the Medical Director of the Hepatobiliary and Pancreatic Surgery Program at Saint John’s Health Center. He will also serve as an associate faculty member at the John Wayne Cancer Institute at Saint John's Health Center, where he will contribute to existing cancer research programs, develop new methods of basic and clinical research, and provide instruction for surgical fellows. He recently moved from University of Southern California- University Hospital where he was an Assistant professor of Surgery at the Keck School of Medicine.
His surgical career began in Bombay (Mumbai) at the Tata Memorial Cancer Center, one of the foremost and best cancer hospital in India, where at the end of his surgical oncology fellowship he moved west to subspecialize in advanced hepatobiliary surgery. To attain expertise, he moved to Paris, spending a year at Hôpital Cochin and the following year at the Royal Liverpool University Hospital in England.
In the U.S.A., he recertified, graduating with the “Resident of the Year Award” from Maricopa Medical Center in Phoenix. He completed his fellowship training at the University of Iowa Hospitals & Clinics, Iowa City; and is certified by the American Boards of Surgery (ABS) and is a Fellow of American College of Surgeons (FACS).
He is a surgical specialist for diseases within the "Liver-Pancreas-Biliary" region and not limited to it. His proficiency extends to all forms of Gastrointestinal Cancers. He has extensive experience and his surgical expertise encompasses all forms of major liver resections, complex pancreatic resections (with vascular reconstruction) and dealing with bile duct cancers, strictures and injuries. His dexterity includes laparoscopic liver and pancreatic surgeries and more recently robotic surgery. He is a surgeon with a difference, a outstanding clinical acumen coupled with a solid surgical background that is very well recognized by his peers.
His research interests include gene therapy strategies for cancer, mechanisms of hepatic gene transfer and developing technical innovations in hepatic and pancreatic surgery. His work is very well published nationally and internationally with several publications in peer-reviewed journals.
|
|
|
In This Section
|
|
|
|
|
|
|
|
|
|